Descamps D - Search Results

1

Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients.

Barrail-Tran A, Yazdanpanah Y, Goldwirt L, Chêne G, Colin C, Piketty C, Bollens D, Katlama C, Descamps D, Molina JM, Fagard C, Taburet AM; ANRS 139 study group. Barrail-Tran A, et al. Among authors: descamps d. AIDS. 2010 Oct 23;24(16):2581-3. doi: 10.1097/qad.0b013e32833d89fa. AIDS. 2010. PMID: 20960678

2

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Meynard JL, Vray M, Morand-Joubert L, Race E, Descamps D, Peytavin G, Matheron S, Lamotte C, Guiramand S, Costagliola D, Brun-Vézinet F, Clavel F, Girard PM; Narval Trial Group. Meynard JL, et al. Among authors: descamps d. AIDS. 2002 Mar 29;16(5):727-36. doi: 10.1097/00002030-200203290-00008. AIDS. 2002. PMID: 11964529 Clinical Trial.

3

Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, Chène G, Matheron S, Campa P, Brun-Vézinet F, Simon F. Damond F, et al. Among authors: descamps d. J Clin Microbiol. 2002 Oct;40(10):3654-9. doi: 10.1128/JCM.40.10.3654-3659.2002. J Clin Microbiol. 2002. PMID: 12354861 Free PMC article.

4

NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.

Joly V, Descamps D, Yeni P. Joly V, et al. Among authors: descamps d. AIDS Rev. 2002 Jul-Sep;4(3):128-39. AIDS Rev. 2002. PMID: 12416447 Review.

5

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.

Calvez V, Costagliola D, Descamps D, Yvon A, Collin G, Cécile A, Delaugerre C, Damond F, Marcelin AG, Matheron S, Simon A, Valantin MA, Katlama C, Brun-Vézinet F. Calvez V, et al. Among authors: descamps d. Antivir Ther. 2002 Sep;7(3):211-8. Antivir Ther. 2002. PMID: 12487389

6

R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.

Masquelier B, Droz C, Dary M, Perronne C, Ferré V, Spire B, Descamps D, Raffi F, Brun-Vézinet F, Chêne G; APROCO/COPILOTE Study Group. Masquelier B, et al. Among authors: descamps d. Antimicrob Agents Chemother. 2003 Nov;47(11):3623-6. doi: 10.1128/AAC.47.11.3623-3626.2003. Antimicrob Agents Chemother. 2003. PMID: 14576131 Free PMC article. Clinical Trial.

7

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.

Chaix ML, Descamps D, Harzic M, Schneider V, Deveau C, Tamalet C, Pellegrin I, Izopet J, Ruffault A, Masquelier B, Meyer L, Rouzioux C, Brun-Vezinet F, Costagliola D. Chaix ML, et al. Among authors: descamps d. AIDS. 2003 Dec 5;17(18):2635-43. doi: 10.1097/00002030-200312050-00011. AIDS. 2003. PMID: 14685058

8

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen.

Descamps D, Damond F, Matheron S, Collin G, Campa P, Delarue S, Pueyo S, Chêne G, Brun-Vézinet F; French ANRS HIV-2 Cohort Study Group. Descamps D, et al. J Med Virol. 2004 Oct;74(2):197-201. doi: 10.1002/jmv.20174. J Med Virol. 2004. PMID: 15332266

9

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.

Masquelier B, Pereira E, Peytavin G, Descamps D, Reynes J, Verdon R, Fleury H, Garraffo R, Chêne G, Raffi F, Brun-Vézinet F; APROCO/COPILOTE Study Group. Masquelier B, et al. Among authors: descamps d. J Clin Virol. 2005 May;33(1):75-8. doi: 10.1016/j.jcv.2004.11.012. J Clin Virol. 2005. PMID: 15797369 Clinical Trial.

10

Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.

Marcelin AG, Cohen-Codar I, King MS, Colson P, Guillevic E, Descamps D, Lamotte C, Schneider V, Ritter J, Segondy M, Peigue-Lafeuille H, Morand-Joubert L, Schmuck A, Ruffault A, Palmer P, Chaix ML, Mackiewicz V, Brodard V, Izopet J, Cottalorda J, Kohli E, Chauvin JP, Kempf DJ, Peytavin G, Calvez V. Marcelin AG, et al. Among authors: descamps d. Antimicrob Agents Chemother. 2005 May;49(5):1720-6. doi: 10.1128/AAC.49.5.1720-1726.2005. Antimicrob Agents Chemother. 2005. PMID: 15855487 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

647 results

Search Page

Filters